Drugmaker Mylan has come under fire this week for price increases upwards of 500% since 2009 to epinephrine autoinjector EpiPen.

As it turns out, this isn’t CEO Heather Bresch’s first brush with controversy. In 2008, West Virginia University stripped her of an MBA she claimed she earned.

The situation began when the Pittsburgh Post-Gazette made a routine call to verify Bresch’s credentials as the new head of Mylan. Accusations of political cronyism and the resignation of three WVU faculty members followed.

In 2007, the press release announcing Bresch’s ascension to CEO noted she “earned an MBA and an undergraduate read more >>>

Source:: BusinessInsider.Com